Project Echo: Tele-mentoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies: Hepatobiliary Toxicities with Immune Checkpoint Inhibitors - March 21, 2023
This page is for learners who attended the March 21, 2023, virtual session to claim credit.
The target audience for this initiative includes oncologists, oncology advanced practice providers (nurse practitioners, physician assistants), oncology pharmacists, oncology nurses, and other healthcare professionals (HCPs) involved in treating patients with cancer immunotherapies.
- Apply evidence-based practices for the monitoring and management of irAEs in patients receiving cancer immunotherapies
- Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAEs in patients receiving cancer immunotherapies
- Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and the Association of Community Cancer Centers. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Contact Hours: 1.0, of which 1.0 is pharmacology credit worthy
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an application-based educational activity. Pharmacists will receive 1.0 contact hour (0.10 CEUS) for the educational activity. No partial credit is available.
UNIVERSAL ACTIVITY NUMBERS (UAN) 0060-9999-22-085-L01-P
Please see the additional information tab in the Overview section for directions on how to claim credit.
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
- 1.00 Participation